Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected develo** COVID-19. Since the beginning of the pandemic in …

The Omicron variant was first detected in October 2021, which evolved from the original
SARS‐CoV‐2 strain and was found to possess many mutations. Immune evasion was one of …

The omicron variant of severe acute respiratory syndrome coronavirus 2 causes much less
olfactory dysfunction than the previous variants. There are several potential mechanisms for …

The omicron variant is thought to cause less olfactory dysfunction than previous variants of
SARS-CoV-2, but the reported prevalence differs greatly between populations and studies …

Anosmia was identified as a hallmark of COVID-19 early in the pandemic, however, with the
emergence of variants of concern, the clinical profile induced by SARS-CoV-2 infection has …

Objective To investigate the prevalence and recovery of olfactory dysfunction (OD) in COVID‐
19 patients 24 months after the infection. Methods From 22 March 2020 to 5 June 2022, 251 …

Despite widespread mass rollout programs, the rapid spread of the SARS-CoV-2 Omicron
variant called into question the effectiveness of the existing vaccines against infection …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with
various neurological complications. Although the mechanism is not fully understood, several …

Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: a
psychophysical case-control study* Page 1 ORIGINAL CONTRIBUTION Prevalence of …

The Omicron variant of SARS-CoV-2 was detected in October 2021 and exhibited high
transmissibility, immune evasion, and reduced severity when compared to the earlier …